Your session is about to expire
What is Osphena
Effectiveness
When to interrupt dosage
The proposed dosage of Osphena is contingent upon the established condition, including Menopause, extreme Dyspareunia and moderate Dyspareunia. The measure also changes according to the technique of delivery featured in the table below.Warnings
Osphena ContraindicationsOsphena Novel Uses: Which Conditions Have a Clinical Trial Featuring Osphena?
16 active clinical trials are evaluating the potential of Osphena to ameliorate Menopause, severe and moderate Dyspareunia.Osphena Reviews: What are patients saying about Osphena?
Patient Q&A Section about osphena
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is Osphena a hormone replacement?
"Osphena is not a form of estrogen. It is an alternative hormone-free option for women who do not want to take estrogen or use estrogen-based products."
Is Osphena a hormone?
"Osphena works by replenishing lacked vaginal moisture, which can result in painful intercourse. The active ingredient in Osphena, ospemifene, is a selective estrogen receptor modulator (SERM).
Osphena is a non-hormonal treatment option for women who do not want to take estrogen or use estrogen-based products. Osphena replenishes vaginal moisture, which can result in painful intercourse. The active ingredient in Osphena, ospemifene, is a selective estrogen receptor modulator (SERM)."
What are side effects of Osphena?
"The following are symptoms of blood clots: leg pain or swelling, skin that's warm to the touch, trouble breathing. The following are symptoms of a stroke: sudden weakness on one side of your body, headache, changes in your speech or vision, confusion. The following are symptoms of a heart attack: chest pain, shortness of breath, arm pain, cold sweat."
Is Osphena safer than estrogen?
"The risks of stroke and deep vein thrombosis (DVT) are increased with estrogen-alone therapy. Cerebral thromboembolic and hemorrhagic stroke incidence rates were 1.13 and 3.39 per thousand women years, respectively, with OSPHENA 60 mg, vs. 3.15 and 0 per thousand women years, respectively, with placebo."